Which of the following most commonly produces osteoblastic secondaries?
Wait, the options aren't provided, so I have to make an educated guess. Typically, in such questions, the options might include prostate, breast, lung, and kidney cancers. The correct answer is likely prostate cancer. Let me check why the other options are incorrect. Breast cancer can also cause osteoblastic lesions, but prostate is more common. Lung cancer usually leads to osteolytic lesions. Renal cell carcinoma might have mixed or lytic. So the correct answer is prostate cancer. The clinical pearl here is that prostate cancer is a classic cause of osteoblastic metastases, and students should remember that. Need to structure the explanation with the required sections and ensure each part is concise and accurate.
**Core Concept**
Osteoblastic bone metastases result from tumor-induced stimulation of bone formation, typically mediated by factors like bone morphogenetic proteins (BMPs) or transforming growth factor-beta (TGF-β). Prostate adenocarcinoma is the most common primary malignancy associated with this pattern due to its high secretion of osteoblast-activating cytokines.
**Why the Correct Answer is Right**
Prostate cancer cells secrete factors (e.g., BMPs, TGF-β) that activate osteoblasts, leading to excessive bone matrix deposition and radiodense "osteoblastic" lesions. This contrasts with osteolytic metastases (e.g., from multiple myeloma or lung cancer), which destroy bone by stimulating osteoclasts. Prostate cancer accounts for ~85% of osteoblastic metastases due to its unique tumor-bone microenvironment interactions.
**Why Each Wrong Option is Incorrect**
**Option A:** Breast cancer can cause mixed lytic/osteoblastic lesions but is less commonly purely osteoblastic.
**Option B:** Renal cell carcinoma typically causes lytic lesions via osteoclast activation.
**Option C:** Lung cancer (non-small cell) predominantly produces lytic or mixed lesions, not osteoblastic.
**Clinical Pearl / High-Yield Fact**
Remember **"PROSTATE = BONE SPURS"** on imaging—osteoblastic metastases are pathognomonic for prostate adenocarcinoma. Always consider this diagnosis in males with elevated PSA and bone pain.
**Correct Answer: C. Prostate cancer**